These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33990203)

  • 1. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.
    Song D; Guo M; Xu S; Song X; Bai B; Li Z; Chen J; An Y; Nie Y; Wu K; Wang S; Zhao Q
    J Exp Clin Cancer Res; 2021 May; 40(1):170. PubMed ID: 33990203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.
    Santos LS; Silva VR; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
    Cell Death Dis; 2023 Dec; 14(12):832. PubMed ID: 38102125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
    Liu XS; Chen YX; Wan HB; Wang YL; Wang YY; Gao Y; Wu LB; Pei ZJ
    Sci Rep; 2024 Feb; 14(1):4042. PubMed ID: 38369589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis.
    Sun L; Yang S; Chi G; Jin X
    Onco Targets Ther; 2018; 11():1583-1593. PubMed ID: 29593424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 Inhibitor NMS-E973 Exerts the Anticancer Effect Against Glioblastoma via Induction of PUMA-Mediated Apoptosis [Retraction].
    Onco Targets Ther; 2024; 17():571-572. PubMed ID: 39011139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
    Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
    J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis.
    Cui Q; Yin K; Zhang X; Ye P; Chen X; Chao J; Meng H; Wei J; Roeth D; Li L; Qin Y; Sun G; Zhang M; Klein J; Huynhle M; Wang C; Zhang L; Badie B; Kalkum M; He C; Yi C; Shi Y
    Nat Cancer; 2021 Sep; 2(9):932-949. PubMed ID: 35121864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Is Dependent on tRNA Pseudouridylation.
    Cancer Discov; 2021 Oct; 11(10):2367. PubMed ID: 34452948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-regulated chaperone function of cyanobacterial Hsp90 and Hsp70: implications for light/dark regulation.
    Akter T; Nakamoto H
    J Biochem; 2021 Dec; 170(4):463-471. PubMed ID: 33993259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism.
    Liu J; Wu XD; Li W; Yuan Z; Yang K; Zhao QS
    Bioorg Chem; 2021 Jul; 112():104963. PubMed ID: 33991836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
    Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
    J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUS7: a targetable epitranscriptomic regulator of glioblastoma growth.
    Zhang DY; Ming GL; Song H
    Trends Pharmacol Sci; 2021 Dec; 42(12):976-978. PubMed ID: 34657723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher expression of pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis.
    Zhang G; Zhu Y; Tan Y; Chen B; Shan S; Zhang G; Lu J
    J Cardiothorac Surg; 2023 Jul; 18(1):222. PubMed ID: 37420297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
    Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
    Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the sources of errors in
    Wang R; Alvarez DA; Crouch BT; Pilani A; Lam C; Zhu C; Hughes P; Katz D; Haystead T; Ramanujam N
    Biomed Opt Express; 2021 Apr; 12(4):2299-2311. PubMed ID: 33996230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
    Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
    Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface.
    Guegueniat J; Halabelian L; Zeng H; Dong A; Li Y; Wu H; Arrowsmith CH; Kothe U
    Nucleic Acids Res; 2021 Nov; 49(20):11810-11822. PubMed ID: 34718722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique.
    Martinez Campos C; Tsai K; Courtney DG; Bogerd HP; Holley CL; Cullen BR
    RNA; 2021 Nov; 27(11):1400-1411. PubMed ID: 34376564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β-catenin pathway.
    Zhang Q; Fei S; Zhao Y; Liu S; Wu X; Lu L; Chen W
    Mol Carcinog; 2023 Feb; 62(2):160-173. PubMed ID: 36222184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.
    Kan G; Wang Z; Sheng C; Chen G; Yao C; Mao Y; Chen S
    Adv Sci (Weinh); 2021 May; 8(10):2004344. PubMed ID: 34026451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.